Stock Comparison
BMRN vs VRTX
Biomarin Pharmaceutical Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.40B
$124.70B
P/E (TTM)
42.5
29.2
Forward P/E
11.9
25.8
Price/Sales
3.5
10.2
Price/Book
1.8
6.4
EV/EBITDA
22.0
24.0
Dividend Yield
—
—
Profitability
Net Margin
8.29%
35.50%
Operating Margin
18.00%
38.10%
Return on Equity
4.48%
24.20%
Return on Assets
4.49%
12.10%
Growth (YoY)
Revenue Growth
2.80%
7.80%
Earnings Growth
-43.10%
61.40%
Price & Risk
Beta
0.2
0.3
52-Week High
$66.28
$507.92
52-Week Low
$49.26
$362.50
Analyst Target
$87.85
$548.69
Compare BMRN and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.